Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Blood|July 8, 2024
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemiasRahul S Vedula, Hannah Q Karp, Jeremy Koob, et al.
Haematologica|December 15, 2022
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidineTheodoros Karantanos, Patric Teodorescu, Marios Arvanitis, et al.
Blood Neoplasia|September 15, 2025
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AMLAndrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, et al.
Hepatology (Baltimore, Md.)|August 3, 2011
MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpointAlexandru V Olaru, Gabriel Ghiaur, Sumitaka Yamanaka, et al.
Biology|April 3, 2021
FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk StratificationAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Leukemia Research|September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literatureKelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Pageof 10